Work

Supplementary Figure S6 from PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: (A) TMA1 WEE1 and PAXIP1 staining (B) 95 cases and 10 controls were analyzed in TMA1, percentage breakdown by histology (C) Percentage breakdown by histology and WEE1/PAXIP1 staining status.

DOI: 10.1158/1535-7163.22507975

Authors: Ankita Jhuraney, Nicholas T. Woods, Gabriela Wright, Lily Rix, Fumi Kinose, Jodi L. Kroeger, Elizabeth Remily-Wood, W. Douglas Cress, John M. Koomen, Stephen G. Brantley, Jhanelle E. Gray, Eric B. Haura, Uwe Rix, Alvaro N. Monteiro

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362612435

Cites:

Cited by:

Related to: 10